Search by Drug Name or NDC
NDC 00404-9977-50 Xylocaine .01; 10 mg/mL; mg/mL Details
Xylocaine .01; 10 mg/mL; mg/mL
Xylocaine is a INFILTRATION; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Henry Schein, Inc.. The primary component is EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS.
Product Information
NDC | 00404-9977 |
---|---|
Product ID | 0404-9977_4bec9662-8e1f-4e9c-9ea9-c67fd4bf11be |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Xylocaine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Lidocaine Hydrochloride and Epinephrine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INFILTRATION; PERINEURAL |
Active Ingredient Strength | .01; 10 |
Active Ingredient Units | mg/mL; mg/mL |
Substance Name | EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS |
Labeler Name | Henry Schein, Inc. |
Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA006488 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00404-9977-50 (00404997750)
NDC Package Code | 0404-9977-50 |
---|---|
Billing NDC | 00404997750 |
Package | 1 VIAL in 1 BAG (0404-9977-50) / 50 mL in 1 VIAL |
Marketing Start Date | 2022-01-10 |
NDC Exclude Flag | N |
Pricing Information | N/A |